Schonfeld Strategic Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$117K	Buy	75,110 +62,002	+473%	+$90.2K	﹤0.01%	1857
2025 Q4	$15.1K	Sell	13,108 -812,525	-98%	-$1.12M	﹤0.01%	1944
2025 Q3	$1.11M	Sell	825,633 -3,750,519	-82%	-$4.26M	0.01%	1309
2025 Q2	$4.33M	Sell	4,576,152 -3,636,841	-44%	-$2.36M	0.03%	612
2025 Q1	$3.78M	Buy	8,212,993 +654,372	+9%	+$413K	0.03%	637
2024 Q4	$5.58M	Buy	7,558,621 +5,676,021	+301%	+$6.84M	0.04%	470
2024 Q3	$2.96M	Buy	1,882,600 +1,311,108	+229%	+$2.33M	0.02%	731
2024 Q2	$3.24M	Sell	571,492 -388,658	-40%	-$697K	0.03%	699
2024 Q1	$5.35M	Buy	+960,150	New	+$2.06M	0.04%	621
2023 Q4	–	Sell	-469,666	Closed	-$512K	–	2077
2023 Q3	$512K	Sell	469,666 -23,476	-5%	-$41.2K	﹤0.01%	1199
2023 Q2	$1.13M	Buy	493,142 +334,142	+210%	+$887K	0.01%	934
2023 Q1	$386K	Buy	159,000 +42,000	+36%	+$96.2K	﹤0.01%	1273
2022 Q4	$223K	Buy	+117,000	New	+$249K	﹤0.01%	1940
2021 Q1	–	Sell	-75,700	Closed	-$259K	–	2001
2020 Q4	$259K	Buy	+75,700	New	+$144K	﹤0.01%	1252
2017 Q4	–	Sell	-15,781	Closed	-$194K	–	828
2017 Q3	$194K	Buy	+15,781	New	+$233K	0.02%	521
2017 Q2	–	Sell	-10,000	Closed	-$143K	–	704
2017 Q1	$143K	Buy	+10,000	New	+$148K	0.01%	559

Other funds holding LXRX